• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Despite increasing cost of insulin, out-of-pocket expenses stable from 2006-2017

byNina Neill, MDandMarc Succi, MD
June 3, 2020
in Chronic Disease, Endocrinology, Public Health
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Insulin costs steadily increased from 2006-2017. However, the out-of-pocket costs to privately insured patients remained consistent, in-part due to decreased cost-sharing.

2. Privately insured consumers with health savings accounts (HSAs) paid significantly more in out of pocket costs in comparison to those with health reimbursement arrangements (HRAs) or no-account plans.

Evidence Rating Level: 3 (Average)

Study Rundown: In order to study trends in insulin costs for privately insured patients, a retrospective analysis of data from more than 612,000 patients was performed. This study determined that while insulin costs rose steadily from 2006-2017, patient reimbursement share requirements decreased. Thus, monthly out of pocket expenses for privately insured patients remained relatively consistent.  Further, the authors stratified this data based on health insurance type (high deductible HSAs, HRAs, and no-account plans).  It was determined that patients with HSAs were responsible for significantly higher monthly out of pocket expenses than those with HRAs.  Patients with no-account plans paid the least per month for insulin. This study had a number of limitations.  Patient demographics were not listed and the majority of patients included in this study had a no-account plan (80%), while only 4% had an HSA.  Additionally, patients who were uninsured or a recipient of medicare or medicaid were not included.

Click to read study, published today in JAMA

Relevant Reading: Cost-Related Insulin Underuse Among Patients With Diabetes

In-Depth [retrospective cohort]: The rising costs of a number of critical pharmaceutical agents, insulin in particular, has been a subject of discussion and attempted reform for many years. In order to study trends in insulin costs, retrospective data analysis was performed using information from more than 612,000 patients obtained through Optum’s Deidentified Clinformatics Data Mart Database from 2006-2017.  Patients were privately insured, had a diabetes diagnoses, and had a record of prior insulin prescription fills. Patients without insurance benefit design data were excluded.

RELATED REPORTS

Metformin use in Type 2 Diabetes associated with decreased risk of joint replacement

Low-carbohydrate, high-fat diet improves glycemic control in type 2 diabetic patients

Diabetes is a risk factor for high platelet reactivity post percutaneous coronary intervention

Accounting for inflation, it was determined that monthly insulin prices have increased from $143/month in 2006 to $394/month in 2017, which is a mean increase of $23 per year.  Out of pocket expenses have remained in the range of $36-$45 per month, despite this increase.  This consistency can likely be explained by consistent decreases in the share of insulin costs for which privately insured patients are responsible for.  In 2006, patients were responsible for 24% of insulin costs, this share has decreased to 10% as of 2017.  Patients with an HSA plan pay significantly more than those with an HRA or no-account plan ($141/month, $108/month, $48/month, respectively, in 2017).

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: diabetesinsulininsurance
Previous Post

Risk of positive COVID-19 diagnosis not associated with ACE inhibitor or angiotensin receptor blocker use

Next Post

Early administration of thrombolytics in ischemic stroke associated with reduced all-cause mortality and readmissions

RelatedReports

Type 2 diabetes associated with reduction in disability-free life years
Chronic Disease

Metformin use in Type 2 Diabetes associated with decreased risk of joint replacement

January 16, 2023
Pediatric DKA associated with recent acute care visits
Cardiology

Low-carbohydrate, high-fat diet improves glycemic control in type 2 diabetic patients

January 11, 2023
Cardiology

Diabetes is a risk factor for high platelet reactivity post percutaneous coronary intervention

December 26, 2022
Solitary kidney not associated with contrast-induced nephropathy
Chronic Disease

Dapagliflozin reduces the risk of hospitalization in patients with chronic kidney disease

December 26, 2022
Next Post
Quick Take: Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial

Early administration of thrombolytics in ischemic stroke associated with reduced all-cause mortality and readmissions

#VisualAbstract: A Non–D2-Receptor-Binding Drug for the Treatment of Schizophrenia

#VisualAbstract: A Non–D2-Receptor-Binding Drug for the Treatment of Schizophrenia

2 Minute Medicine Rewind October 12 – 19, 2014

Carotid endarterectomy and medical therapy reveal similar effectiveness in asymptomatic carotid stenosis

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • BNT162b2 booster is safe and reduces COVID-19 transmission in older adults
  • Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk
  • Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options